Search PubMed⌕ Search

Biomedical subjects

H Nishida

Publications and source records attributed to H Nishida.

At least 325 records · Page 18Linked to original sources
PubMed1993

[Effects of exercise in the growing stage in mice and of Astragalus membranaceus on immune functions].

A study was carried out to examine the effects of forced running exercise in the growing stage in male ICR mice and of Astragalus membranaceus (As) on their immune functions. The mice were divided at 4 weeks of age into 4 groups. The first group of mice received forced running exercise (E-group), the second group was given As (As-group), the third group received the forced running exercise and was given As (E+As-group) and the fourth group was a control receiving no treatment. The exercise received was forced running at 15 m/min on a flat floor without any slope for 60min a day. The mice of groups E and E+As were exercised 5 times a week for 12 weeks. The mice of groups As and E+As were given As p. o. at 200 mg/kg per day (5 days/week) for 12 weeks. The results obtained were as follows: 1. After 12 weeks of forced running exercise, the weight of the anterior tibialis muscle and succinate dehydrogenase activity in the anterior tibialis muscle increased significantly in groups E and E+As compared with the control group. Thymus weight showed a tendency to increase in groups E and E+As as compared with the control group. 2. The potentiation of the phagocytic function of the reticuloendothelial system examined by the carbon clearance method was seen in groups E, As and E+As. 3. Superoxide anion production of peritoneal macrophages significantly increased in groups As and E+As, but not in group E. 4. The acid phosphatase activity of peritoneal macrophages in groups E, As and E+As significantly increased compared with the control group. 5. Interleukin 1 production by macrophages remained in all groups. 6. The proliferation of splenocytes induced by Con A in groups E, As and E+As significantly increased compared with the control group. These results suggested that forced running exercise in the growing stage in mice and the administration of As enhanced immune functions and that they might also intensify the functioning of the host defense system.

Acid Phosphatase↗
PubMed1993

[Effects of exercise on immune functions in mice].

This study was carried out to examine the effects of forced running exercise on the immune functions of male ICR mice. Mice aged 4 weeks were divided into two groups: a non-exercise group (control) and a group given forced running exercise (exercise group). The exercise applied was forced running at 15m/min on a flat floor without any slope for 60 min a day. The duration of exercise was 5 days per week for 12 weeks. The results obtained were as follows: 1) After 12 weeks of forced running exercise, the weight of the anterior tibialis muscle and succinate dehydrogenase activity in the anterior tibialis muscle increased significantly (p < 0.01) in the exercise group compared with the control group. A tendency for thymus weight to increase was shown in the exercise group, and liver and spleen weights were significantly (p < 0.01) greater than in the control group. 2) The potentiation of phagocytic function of the reticulo-endothelial system, examined by the carbon clearance method, was seen in the exercise group. 3) The ability of peritoneal macrophages (M phi) to phagocytose latex beads significantly increased (p < 0.01) in the exercise group. The acid phosphatase activity of peritoneal M phi remained in both groups. However, lactate dehydrogenase activity of peritoneal M phi significantly increased (p < 0.01) in the exercise group compared with the control group. 4) The proliferation of splenocytes induced by Con A in the exercise group significantly increased (p < 0.01) compared with the control group.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1993

Evolutionary position of n-alkane-assimilating yeast Candida maltosa shown by nucleotide sequence of small-subunit ribosomal RNA gene.

We clarified the evolutionary position of Candida maltosa, an n-alkane-assimilating yeast, by sequencing the nucleotides of the small-subunit ribosomal RNA gene. Phylogenetic analyses showed the close evolutionary relationships of C. maltosa with C. tropicalis, C. viswanathii, C. albicans, C. parapsilosis, and C. guilliermondii, forming a sub-group within this genus.

Alkanes↗
PubMed1993

Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.

To investigate the efficacy of intravenous methylprednisolone pulse therapy on Graves' ophthalmopathy (GO), fifteen patients with severe GO were treated with large dose intravenous methylprednisolone (at a daily dosage of 1 g for 3 successive days). This treatment was repeated 3-5 times for 3-5 weeks. They were monitored before, 2 weeks after and 6 months after therapy by ophthalmological assessment, orbital magnetic resonance imaging (MRI), and by measuring serum antibodies to rat eye muscle (EMAB) in an enzyme linked immunosorbent assay and peripheral blood lymphocyte subsets by flow cytometry. Diplopia and periorbital edema markedly improved after treatment in 9 patients. Mean proptosis values and intraocular pressure measurements significantly decreased after pulse therapy. In 12 patients enlarged eye muscles significantly reduced in size after treatment, as determined by MRI. The overall ophthalmopathy index was improved from 4.8 +/- 2.4 to 2.5 +/- 1.6 at the end of pulse therapy (P < 0.01) and 2.4 +/- 1.5 six months after therapy (P < 0.01). Serum EMAB were detected in 8 out of 10 patients tested and their level significantly decreased after pulse therapy (from 3.3 +/- 1.4 to 2.5 +/- 1.2, P < 0.01). A significant increase in peripheral blood CD4+CD45RA+ cells was observed after pulse therapy. Increased numbers of CD11-CD8+ cells and decreased numbers of CD11+CD8++ cells were found prior to treatment and were normalized after pulse therapy. Our study indicates that methylprednisolone pulse therapy can be considered as a choice for the treatment of GO. The improvement in eye muscle involvement in these patients may be due to the effects of infused methylprednisolone on both humoral and cellular immune functions.

Adult↗
PubMed1993

Enzymatic dimerization of penicillin X.

Penicillin X methyl ester was transformed into three types of dimer by laccase from Coriolus versicolor. The dimers are considered to be formed by free-radical addition of phenoxy radicals produced by laccase. The enzyme reaction with the ester as substrate was more suitable for forming dimers than that with the sodium salt as substrate. Penicillin X pivaloyloxymethyl ester was also transformed into a dimer, which had antibacterial activity in the presence of esterase.

Anti-Bacterial Agents↗
PubMed1993

Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.

A daunorubicin-blocked mutant strain RPM-5 derived from a new baumycin-producing Streptomyces sp. D788 accumulated a major precursor metabolite D788-1 (10-carboxyl-13-deoxocarminomycin) and nine minor metabolites in the culture broth. Five among them were new with a substituent at C-10 or the altered side chains at C-9. Isolation, purification and identification of all anthracycline metabolites produced by strain RPM-5 are described with their antitumor activities against L1210 cells.

Animals↗
PubMed1993

[Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].

Twenty patients with unresectable hepatocellular carcinoma were treated by intra-arterial subsegmental injection of Cisplatin/4-0-Tetrahydro-Pyranyl-adriamycin Lipiodol suspension (CTLS). The mean single doses of Lipiodol, cisplatin and THP were 2.3 ml, 85 mg and 8.9 mg, respectively. The therapy was given once in 10 patients, twice in 8 and 3 times in two. Over 25% reduction in tumor size was recognized in 12 patients (60%). Fifty or more % decrease of alfa-feto-protein (AFP) was observed in all of 7 patients (100%) with the initial serum AFP level of more than 200 ng/ml. Although transitional and mild symptoms, such as fever, abdominal pain and vomiting were recognized in some cases, no severe complications were encountered. This method is promising as an excellent procedure for unresectable hepatocellular carcinoma.

Aged↗
PubMed1993

Flow study of coronary-coronary bypass grafting.

Coronary-coronary bypass grafting was recently introduced for patients with either calcification of the ascending aorta or an inadequate length of graft. Flow in the coronary-coronary bypass graft and that in aortocoronary bypass to the same coronary bed was compared in eight mongrel dogs. Flow reserve of the proximal right coronary artery as a donor vessel to the coronary-coronary bypass graft was also measured. Both a coronary-coronary and aortocoronary bypass were constructed to the proximally ligated left anterior descending artery. The flow in each graft was measured with the other graft temporarily occluded. Flow reserve of the right coronary artery (mean internal diameter 1.5mm) proximal to the anastomosis was measured before and after opening of the coronary-coronary bypass. Mean(s.d.) flow as 50.0(12.3) ml/min in the coronary-coronary bypass graft and 54.9(14.8) ml/min in the aortocoronary bypass, which was not significantly different. Flow curve studies demonstrated early systolic flow reversal in the aortocoronary bypass, while the coronary-coronary bypass showed only forward flow. Mean(s.d.) flow in the proximal right coronary artery increased from 35.4(11.8) to 76.0(15.3) ml/min after opening the coronary-coronary bypass graft, which had a flow rate of 42.2(10.4) ml/min. It is concluded that the coronary-coronary bypass graft can provide nearly the same flow rate as aortocoronary bypass, and that the proximal right coronary artery has sufficient flow reserve for this technique.

Anastomosis, Surgical↗
PubMed1993

[A report of two cases of coronary bypass surgery after renal transplantation].

Coronary artery bypass surgery was performed in two patients who had had renal transplantation. They had been taking immunosuppressive therapy. There were some problems in the management of these patients including prevention of postoperative infection, renal damage due to cyclosporin, and rejection of the transplanted kidney. Immunosuppressive therapy was continued under the meticulous monitoring of blood cyclosporin levels, blood T-cell subsets, markers of infection such as antiviral titers. The anticipated problems were not encountered in both cases. This is the first report in Japan which describes successful coronary artery bypass surgery for kidney transplant recipients.

Coronary Artery Bypass↗
PubMed1993

[Mechanical circulatory support for profound heart failure].

Profound heart failure, such as acute myocardial infarction with cardiogenic shock and postcardiotomy ventricular failure, requires mechanical circulatory support when recent medical treatment is ineffective. Intra-aortic balloon pumping, venoarterial bypass, cardiopulmonary bypass, left ventricular bypass, biventricular bypass and left ventricular assist device are commonly used circulatory support methods. Type selection and application timing of circulatory supports, based on the understanding of type of cardiac failure, respiratory function and other organ conditions, appears to be most important for successful treatment of profound heart failure.

Assisted Circulation↗
PubMed1993

Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).

We evaluated the effects of intraarterial injection of Adriamycin/Mitomycin C oil (Lipiodol) suspension (ADMOS) alone and ADMOS+cis-diaminodichloroplatinum (CDDP) in 135 patients with hepatocellular carcinoma (HCC). A total of 59 patients received ADMOS alone and 76 patients received ADMOS+CDDP (ADMOS/CDDP). Tumor size was reduced by over 25% in 13 (34%) of the evaluable 38 patients in the ADMOS-alone group and in 39 (51%) of the 76 evaluable patients in the ADMOS/CDDP group. Serum alpha-fetoprotein (AFP) levels decreased by more than 50% in 10 (59%) of 17 ADMOS-alone patients and in 23 (70%) of 33 ADMOS/CDDP patients whose pretreatment AFP levels were above 0.2 mg/l. The overall one- and 2-year survival rates were 68% and 41%, respectively. No severe complications and no significant changes in laboratory values were observed, except for one patient in the ADMOS/CDDP group who developed a liver abscess. Although the tumor response was significantly better in patients treated by ADMOS/CDDP than in those treated by ADMOS-alone (p < 0.05), there was no significant difference in the survival rates between the 2 groups. The intraarterial injection of ADMOS and CDDP was concluded to be effective in treating HCC judging by tumor response.

Antineoplastic Combined Chemotherapy Protocols↗